Minnesota’s two medical marijuana companies lost a combined $2.4 million in 2018, adding to years of losses that have largely been driven by the state’s tightly regulated program. Leafline Labs, which has never had a profitable year, reported a net income loss of $1.8 million in 2018, according to... Read more

Minnesotans over 21 would could buy and use marijuana legally by 2022 as part of a proposal that would give the state significant power and oversight of a recreational cannabis program. The state would regulate all aspects of the local marijuana industry, enforcing health and safety regulations and controlling... Read more